Josemir W Sander1,2,3, Jan Novy4, Mark R Keezer5,6,7,8. 1. UCL Institute of Neurology, NIHR University College London Hospitals Biomedical Research Centre, London, UK. 2. Epilepsy Society, Chalfont St Peter, UK. 3. Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands. 4. Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. 5. UCL Institute of Neurology, NIHR University College London Hospitals Biomedical Research Centre, London, UK. mark.keezer.chum@ssss.gouv.qc.ca. 6. Epilepsy Society, Chalfont St Peter, UK. mark.keezer.chum@ssss.gouv.qc.ca. 7. Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands. mark.keezer.chum@ssss.gouv.qc.ca. 8. Centre Hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, 3ième pavillon Deschamps, porte H-3110, 1560 rue Sherbrooke est, Montréal, Québec, H2L 4M1, Canada. mark.keezer.chum@ssss.gouv.qc.ca.
Authors: Robert S Fisher; Carlos Acevedo; Alexis Arzimanoglou; Alicia Bogacz; J Helen Cross; Christian E Elger; Jerome Engel; Lars Forsgren; Jacqueline A French; Mike Glynn; Dale C Hesdorffer; B I Lee; Gary W Mathern; Solomon L Moshé; Emilio Perucca; Ingrid E Scheffer; Torbjörn Tomson; Masako Watanabe; Samuel Wiebe Journal: Epilepsia Date: 2014-04-14 Impact factor: 5.864
Authors: George E Dafoulas; Konstantinos A Toulis; Dougall Mccorry; Balachadran Kumarendran; G Neil Thomas; Brian H Willis; Krishna Gokhale; George Gkoutos; Parth Narendran; Krishnarajah Nirantharakumar Journal: Diabetologia Date: 2016-10-31 Impact factor: 10.122